What is it about?
The aim of this study is to develop 177Lu-5-Flourouracil as a potential cancer therapeutic radiopharmaceutical. 5-Flourouracil (5-FU) is widely accepted as an anticancer drug of broad spectrum fame. The labeling of 5-FU was carried out to make it the radiopharmaceutical of choice for further testing in patients for therapeutic purposes.
Featured Image
Perspectives
The labeling of 5-FU will be utilized for further testing in patients for therapeutic purposes of mailignancies.
Dr. Syed Ali Raza SAR Naqvi
Government College University Faisalabad
Read the Original
This page is a summary of: 177Lu-5-Fluorouracil a potential theranostic radiopharmaceutical: radiosynthesis, quality control, biodistribution, and scintigraphy, Journal of Labelled Compounds, July 2016, Wiley,
DOI: 10.1002/jlcr.3423.
You can read the full text:
Contributors
The following have contributed to this page
